Risk of neuropsychiatric and related conditions associated with SARS-CoV-2 infection: a difference-in-differences analysis

The COVID-19 pandemic has been associated with increased neuropsychiatric conditions in children and youths, with evidence suggesting that SARS-CoV-2 infection may contribute additional risks beyond pandemic stressors. This study aims to assess the full spectrum of neuropsychiatric conditions in COVID-19 positive children (ages 5-12) and youths (ages 12-20) compared to a matched COVID-19 negative cohort, accounting for factors influencing infection risk. Using EHR data from 25 institutions in the RECOVER program, we conduct a retrospective analysis of 326,074 COVID-19 positive and 887,314 negative participants matched for risk factors and stratified by age. Neuropsychiatric outcomes are examined 28 to 179 days post-infection or negative test between March 2020 and December 2022. SARS-CoV-2 positivity is confirmed via PCR, serology, or antigen tests, while negativity requires negative test results and no related diagnoses. Risk differences reveal higher frequencies of neuropsychiatric conditions in the COVID-19 positive cohort. Children face increased risks for anxiety, OCD, ADHD, autism, and other conditions, while youths exhibit elevated risks for anxiety, suicidality, depression, and related symptoms. These findings highlight SARS-CoV-2 infection as a potential contributor to neuropsychiatric risks, emphasizing the importance of research into tailored treatments and preventive strategies for affected individuals.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2025-07-24
DOI
https://doi.org/10.1038/s41467-025-61961-1
Citations
4
Primary Topic
Long-Term Effects of COVID-19
Type
article
Field-Weighted Citation Impact
5.56

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Risk of neuropsychiatric and related conditions associated with SARS-CoV-2 infection: a difference-in-differences analysis

Dimitri Christakis, Christopher B. Forrest, W. Schuyler Jones, Jiayi Tong et al.
4 citations
Nature Communications
Long-Term Effects of COVID-19
5.56
article

Risk of neuropsychiatric and related conditions associated with SARS-CoV-2 infection: a difference-in-differences analysis

Dimitri Christakis, Christopher B. Forrest, W. Schuyler Jones, Jiayi Tong, Dazheng Zhang, Jonathan Platt, Hayden T. Schwenk, Ravi R. Jhaveri, David A. Williams, Abu Saleh Mohammad Mosa, Lu Li, Nathan J. Blum, Mady Hornig, Bradley Taylor, Kathleen Pajer, Josephine Elia, Levon Utidjian, Kelly J. Kelleher, Michael J. Becich, Saul Blecker, Leyna Aragon, Yong Chen, Susan Kim, Yuqing Lei, Ting Zhou, Jiajie Chen, Amber Brown Keebler, Yiwen Lu, Raghuram Prasad, Maxwell M. Hornig-Rohan
article en
4 citations

Abstract

The COVID-19 pandemic has been associated with increased neuropsychiatric conditions in children and youths, with evidence suggesting that SARS-CoV-2 infection may contribute additional risks beyond pandemic stressors. This study aims to assess the full spectrum of neuropsychiatric conditions in COVID-19 positive children (ages 5-12) and youths (ages 12-20) compared to a matched COVID-19 negative cohort, accounting for factors influencing infection risk. Using EHR data from 25 institutions in the RECOVER program, we conduct a retrospective analysis of 326,074 COVID-19 positive and 887,314 negative participants matched for risk factors and stratified by age. Neuropsychiatric outcomes are examined 28 to 179 days post-infection or negative test between March 2020 and December 2022. SARS-CoV-2 positivity is confirmed via PCR, serology, or antigen tests, while negativity requires negative test results and no related diagnoses. Risk differences reveal higher frequencies of neuropsychiatric conditions in the COVID-19 positive cohort. Children face increased risks for anxiety, OCD, ADHD, autism, and other conditions, while youths exhibit elevated risks for anxiety, suicidality, depression, and related symptoms. These findings highlight SARS-CoV-2 infection as a potential contributor to neuropsychiatric risks, emphasizing the importance of research into tailored treatments and preventive strategies for affected individuals.

Nature CommunicationsVol. 16(1)
University of Iowa (US), Lurie Children's Hospital (US), Seattle Children's Hospital (US), Northwell Health (US), Nationwide Children's Hospital (US), Feinstein Institute for Medical Research (US), Children's Hospital of Philadelphia (US), Johns Hopkins University (US), University of New Mexico (US), University of Pittsburgh (US), Medical College of Wisconsin (US), University of the Philippines Mindanao (PH), University of Michigan (US), Children's Hospital of Eastern Ontario (CA), University of the Arts (US), University of Alabama at Birmingham (US), Clinical Research Institute (US), Nemours Children's Health System (US), Penn Center for AIDS Research (US), Applied Mathematics (United States) (US), UCSF Benioff Children's Hospital (US), Stanford Medicine (US), Duke University Health System (US), Patient Advocate Foundation (US), New York University (US), University of Nebraska Medical Center (US), University of Missouri (US), University of Pennsylvania (US)
National Institutes of Health
Openalex Percentile: Top 4%
Long-Term Effects of COVID-19
5.56
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.